Expanding capacity to synthesize, purify, and test active pharmaceutical ingredients (APIs).
Unlocking Africa’s pharmaceutical future through strong regulatory systems
Building capacity in Africa to conduct bioequivalence studies
Our global health programs increase the supply of safe and effective medicines, vaccines, and trusted diagnostics. We’ve reached more than 90 countries across Africa, Asia, and North and South America to strengthen health systems and deliver end-to-end pharmaceutical services that champion equitable access to quality medical products.
Download the brochure View our latest newsletter Sign up for updates Register for events
Bioequivalence (BE) studies are essential to assuring the quality of generic medicines, but challenging to complete without proper business planning.
Increasing the supply of medicines improves resiliency, self-reliance, and global health security
With support from Unitaid and the EU, the MedSuRe Africa project is expanding regional production of quality-assured, African-made medicines.
